GenMark Diagnostics, Inc.·4

Apr 3, 5:10 PM ET

Mitchell Brian Andrew 4

4 · GenMark Diagnostics, Inc. · Filed Apr 3, 2020

Insider Transaction Report

Form 4
Period: 2020-04-01
Mitchell Brian Andrew
SVP, Operations
Transactions
  • Sale

    Common Stock

    2020-04-01$3.99/sh2,000$7,980255,663 total
Footnotes (2)
  • [F1]The shares were sold pursuant to a Rule 10b5-1 Plan adopted by Reporting Person in December 2019.
  • [F2]The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $3.97 to $4.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_158594820920356.xmlPrimary

    FORM 4